Sodium-glucose cotransporter-2 inhibitors and the risk of urinary tract infection among diabetic patients in Japan: Target trial emulation using a nationwide administrative claims database.
Yoshinori TakeuchiHiraku KumamaruYasuhiro HagiwaraHiroki MatsuiHideo YasunagaHiroaki MiyataYutaka MatsuyamaPublished in: Diabetes, obesity & metabolism (2021)
Use of SGLT2 inhibitors or DPP-4 inhibitors did not increase the risk of UTI compared with biguanide use. Accounting for treatment changes did not substantially influence the estimated effects.